Table 3:

Multivariable Logistic Regression of Persistent Postoperative Gabapentinoid Use

Characteristic	Odds Ratio (95% CI)	P-Value
Age
18-29	0.57 (0.36-0.90)	<0.05
30-39	0.73 (0.59-0.89)	<0.05
40-49	0.83 (0.72-0.96)	<0.05
50-59	1 [Reference]	-
60-64	1.00 (0.85-1.15)	0.85
Female	1.09 (0.97-1.23)	0.17
Median Household Income
<60,000	1.12 (0.96-1.31)	0.16
60,000-69,999	1 [Reference]	-
70,000-79,999	0.99 (0.83-1.18)	0.88
80,000-89,999	0.88 (0.67-1.15)	0.34
≥90,000	1.25 (1.08-1.44)	<0.05
Charlson Comorbidity Index	1.11 (1.06-1.17)	<0.05
Diabetes	1.38 (1.19-1.61)	<0.05
Region
South	1 [Reference]	-
North Central	0.91 (0.79-1.05)	0.18
Northeast	0.81 (0.68-0.96)	<0.05
West	0.83 (0.69-1.00)	0.05
Insurance
PPO	1 [Reference]	-
Comprehensive	1.31 (1.04-1.65)	<0.05
HMO	0.95 (0.79-1.14)	0.59
Point of Service	1.15 (0.95-1.38)	0.15
Other	0.84 (0.69-1.03)	0.10
Mental Health Disorders
Adjustment	1.38 (1.02-1.88)	<0.05
Anxiety	1.24 (1.03-1.50)	<0.05
Disruptive	0.75 (0.46-1.22)	0.25
Mood	1.09 (0.93-1.29)	0.30
Suicide of Self-Harm	0.84 (0.23-3.03)	0.78
Personality	3.98 (1.64-9.68)	<0.05
Psychosis	1.17 (0.42-3.26)	0.76
Alcohol or Substance Abuse	1.20 (0.80-1.80)	0.38
Other	0.71 (0.46-1.12)	0.14
Pain Disorders
Arthritis	1.13 (1.01-1.27)	<0.05
Back	1.41 (1.24-1.60)	<0.05
Neck	1.03 (0.89-1.20)	0.67
Other	1.24 (1.09-1.40)	<0.05
Preoperative Gabapentinoid Use	21.40 (19.16-23.91)	<0.05